These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27699536)

  • 1. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.
    Rieke DT; Keilholz U
    Recent Results Cancer Res; 2017; 206():149-160. PubMed ID: 27699536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature.
    Flach S; Maniam P; Hey SY; Manickavasagam J
    Clin Otolaryngol; 2024 Jul; 49(4):384-403. PubMed ID: 38658385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
    Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
    Front Immunol; 2021; 12():652054. PubMed ID: 34305889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
    Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
    Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC.
    Coppock JD; Vermeer PD; Vermeer DW; Lee KM; Miskimins WK; Spanos WC; Lee JH
    Oncotarget; 2016 Apr; 7(17):24228-41. PubMed ID: 27015118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    Sacco AG; Cohen EE
    J Clin Oncol; 2015 Oct; 33(29):3305-13. PubMed ID: 26351341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?
    Vermorken JB
    Recent Results Cancer Res; 2017; 206():137-147. PubMed ID: 27699535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.
    Dok R; Bamps M; Glorieux M; Zhao P; Sablina A; Nuyts S
    Int J Cancer; 2020 Feb; 146(4):1075-1085. PubMed ID: 31283004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
    Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
    Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Factors for Outcome and Quality of Life in HPV-Positive and HPV-Negative HNSCC.
    Hess J
    Recent Results Cancer Res; 2017; 206():233-242. PubMed ID: 27699543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
    Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
    Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Misiukiewicz K; Camille N; Gupta V; Bakst R; Teng M; Miles B; Genden E; Sikora A; Posner M
    Clin Adv Hematol Oncol; 2014 Dec; 12(12):812-9. PubMed ID: 25674839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.
    Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM; Ferris RL;
    Mol Cancer Res; 2017 Feb; 15(2):179-188. PubMed ID: 27899422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus-related head and neck tumors: clinical and research implication.
    Psyrri A; Gouveris P; Vermorken JB
    Curr Opin Oncol; 2009 May; 21(3):201-5. PubMed ID: 19370803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist.
    Westra WH
    Semin Diagn Pathol; 2015 Jan; 32(1):42-53. PubMed ID: 25804343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV-Related Head and Neck Squamous Cell Carcinomas.
    Marszałek A; Szylberg Ł
    Recent Results Cancer Res; 2017; 206():89-100. PubMed ID: 27699531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.